Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay

Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF

(2014) Nobuto Yamamoto et al.   Translational Oncology

A Paradox of Cadmium: A Carcinogen That Impairs the Capability of Human Breast Cancer Cells To Induce Angiogenesis

(2012) Stefania Pacini et al.   JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

Angiogenesis: What can it offer for future medicine?

(2010) Yihai Cao   EXPERIMENTAL CELL RESEARCH

Treatment of thromboembolism in cancer patients

(2010) Marina Panova-Noeva et al.   EXPERT OPINION ON PHARMACOTHERAPY

Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity

(2009) Marilena Greco et al.   CANCER LETTERS

Prostaglandin E2 Inhibits Advanced Glycation End Product-Induced Adhesion Molecule Expression, Cytokine Production, and Lymphocyte Proliferation in Human Peripheral Blood Mononuclear Cells

(2009) H. K. Takahashi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Retracted: Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF)

(2008) Nobuto Yamamoto et al.   JOURNAL OF MEDICAL VIROLOGY